Familial Cancer (FC)

In recent years clinical cancer genetics has become increasingly important. Several events, in particular the developments in DNA-based technology, have contributed to this evolution. Clinical cancer genetics has now matured to a medical discipline which is truly multidisciplinary in which clinical and molecular geneticists work together with clinical and medical oncologists as well as with psycho-social workers. Due to the multidisciplinary nature of clinical cancer genetics most papers are currently being published in a wide variety of journals on epidemiology, oncology and genetics. Familial Cancer provides a forum bringing these topics together focusing on the interests and needs of the clinician. The journal mainly concentrates on clinical cancer genetics. Most major areas in the field shall be included, such as epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counselling and the health economics of familial cancer.

Familial Cancer (FC) is :-

• International, Peer-Reviewed, Open Access, Refereed, epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counseling, and the health economics of familial cancer, Clinical cancer genetics, oncology, hereditary cancer risk, and related multidisciplinary research, genetic predisposition to cancer, health economics of familial cancer , Online or Print , Quarterly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1389-9600, E-ISSN: 1573-7292, Established: 2001, Impact Factor: 2.0
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE